1] Sigfrid L, Cevik M,
Jesudason E, Lim WS, Rello J, Amuasi JH, et al. What is the recovery
rate and risk of long-term consequences following a diagnosis of
COVID-19? A harmonised, global longitudinal observational study. BMJ
Open. ( 2021 ) 11:e043887. doi: 10.1101/2020.08.26.20180950.
[2] Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. Sandra
Lopez-Leon, Talia Wegman-Ostrosky, Carol Perelman, Rosalinda Sepulveda,
Paulina A Rebolledo, Angelica Cuapio, Sonia Villapol; More than 50
Long-term effects of COVID-19: a systematic review and
meta-analysis.medRxiv : the preprint server for health sciences 2021 Jan
30; doi:10.1101/2021.01.27.21250617.
[3] Cheung OY, Chan JWM, Ng CK, Koo CK. The spectrum of pathological
changes in severe acute respiratory syndrome ( SARS ) . Histopathology.
2004;45(2) :119-124. 10.1111/j.1365-2559.2004.01926.x.
[4] Lindsay T McDonald; Healing after COVID-19: are survivors at
risk for pulmonary fibrosis?American journal of physiology. Lung
cellular and molecular physiology 2021 02 01;320(2):L257-L265
doi:10.1152/ajplung.00238.2020.
[5] Fuzhou Wang, Richard M Kream, George B Stefano; Long-Term
Respiratory and Neurological Sequelae of COVID-19.Medical science
monitor : international medical journal of experimental and clinical
research 2020 Nov 01;26:e928996 doi:10.12659/MSM.928996.
[6] Zhao X, Nicholls JM, Chen YG. Severe acute respiratory
syndrome-associated coronavirus nucleocapsid protein interacts with
Smad3 and modulates transforming growth factor-β signaling. J Biol
Chem. 2008;283(6 ) :3272-3280. 10.1074/jbc.M708033200.
[7] Lal SK. Molecular biology of the SARS-coronavirus. Springer.
2010:1- 328. 10.1007/978-3-642-03683-5.
[8] Qiuyue Long, Jiwei Li, Xiaoyi Hu, Yangyuyan Bai, Yali Zheng,
Zhancheng Gao; Follow-Ups on Persistent Symptoms and Pulmonary Function
Among Post-Acute COVID-19 Patients: A Systematic Review and
Meta-Analysis.Frontiers in medicine 2021;8:702635
doi:10.3389/fmed.2021.702635.
[9] Balasubramanian A, MacIntyre NR, Henderson RJ, et al. Diffusing
capacity of carbon monoxide in assessment of COPD. CHEST.
2019;156:1111–1119.
[10] Gattinoni L, Marini JJ, Busana M, Chiumello D, Camporota L.
Spontaneous breathing, transpulmonary pressure and mathemat- ical
trickery. Ann Intens Care. 2020;10(1) :1-2. 10.1186/s13613-020-
00708-1.
[11] Tobin MJ, Laghi F, Jubran A. Caution about early intubation and
mechanical ventilation in COVID-19. Ann Intens Care. 2020;10(1) :4- 6.
doi:10.1186/s13613-020-00692-6.
[12] Clinical management of severe acute respiratory infection when
COVID-19 is suspected.Released by World Health Organization on 13 March
2020.
https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-
infection-when-novel-coronavirus-( ncov )-infection-is- suspected.
[13] General Office of National Health Commission of the People’s
Republic of China. Office of National Administration of Traditional
Chinese Medicine. Diagnosis and treatment of corona virus disease-19 (
8th trial edition ) [J]. China Medicine, 2020, 15( 10 )
:1494-1499.(in Chinese ).
[14] Jin Meiling, Song Yuanlin, Zheng Jinping, et al.Guideline for
pulmonary function testing in primary care ( 2018 ) , Chinese Journal of
General Practitioners, 2019,18(6) : 511-518.
[15] Graham BL, Steenbruggen I, Miller MR, et al. Standardization of
Spirometry 2019 Update. An Official American Thoracic Society and
European Respiratory Society Technical Statement. Am J Respir Crit Care
Med 2019;200( 8 ) :e70–88.
[16] Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term
impact of severe acute respiratory syndrome on pulmonary function,
exercise capacity and health status. Respirology 2010;15( 3 ) :543–50.
[17] D S Hui, G M Joynt, K T Wong, C D Gomersall, et al; Impact of
severe acute respiratory syndrome ( SARS ) on pulmonary function,
functional capacity and quality of life in a cohort of survivors.Thorax
2005 May;60( 5 ) :401-9 doi:10.1136/thx.2004.030205.
[18] Lixin Xie, Youning Liu, Yueyong Xiao, et al; Follow-up study on
pulmonary function and lung radiographic changes in rehabilitating
severe acute respiratory syndrome patients after discharge.Chest 2005
Jun;127( 6 ) :2119-24 doi:10.1378/chest.127.6.2119.
[19] Jenny C Ngai, Fanny W Ko, Susanna S Ng, et al; The long-term
impact of severe acute respiratory syndrome on pulmonary function,
exercise capacity and health status.Respirology ( Carlton, Vic. ) 2010
Apr;15( 3 ) :543-50 doi:10.1111/j.1440-1843.2010.01720.x.
[20] Wan Beom Park, Kang Il Jun, Gayeon Kim, Jae-Phil Choi,et al;
Correlation between Pneumonia Severity and Pulmonary Complications in
Middle East Respiratory Syndrome.Journal of Korean medical science 2018
Jun 11;33( 24 ) :e169 doi:10.3346/jkms.2018.33.e169.
[21] Svander Sarvan der Brugge, Stalman, Ljm Boonmande Winter, et
al; Pulmonary function and health-related quality of life after COVID-19
pneumonia.Respiratory medicine 2021 01;176:106272
doi:10.1016/j.rmed.2020.106272.
[22] Tori Vigeland Lerum, Trond Mogens Aaløkken, Eivind Bronstad, et
al; Dyspnoea, lung function and CT findings 3 months after hospital
admission for COVID-19.The European respiratory journal 2021 Apr;57( 4 )
doi:10.1183/13993003.03448-2020
[23] Xiaoneng Mo, Wenhua Jian, Zhuquan Su,et al; Abnormal pulmonary
function in COVID-19 patients at time of hospital discharge.The European
respiratory journal 2020 Jun;55(6) doi:10.1183/13993003.01217-2020.
[24] Sabina A Guler, Lukas Ebner, Catherine Aubry-Beigelman, et al;
Pulmonary function and radiological features 4 months after COVID-19:
first results from the national prospective observational Swiss COVID-19
lung study.The European respiratory journal 2021 04;57(4)
doi:10.1183/13993003.03690-2020.
[25] Chaolin Huang, Lixue Huang, Yeming Wang, et al; 6-month
consequences of COVID-19 in patients discharged from hospital: a cohort
study.Lancet (London, England) 2021 01 16;397(10270):220-232
doi:10.1016/S0140-6736(20)32656-8.
[26] Xiaojun Wu, Xiaofan Liu, Yilu Zhou, et al; 3-month, 6-month,
9-month, and 12-month respiratory outcomes in patients following
COVID-19-related hospitalisation: a prospective study.The Lancet.
Respiratory medicine 2021 07;9(7):747-754
doi:10.1016/S2213-2600(21)00174-0.
[27] Lixue Huang, Qun Yao, Xiaoying Gu, et al; 1-year outcomes in
hospital survivors with COVID-19: a longitudinal cohort study.Lancet
(London, England) 2021 08 28;398(10302):747-758
doi:10.1016/S0140-6736(21)01755-4.
[28] Yuhui Wang, Chengjun Dong, Yue Hu,et al; Temporal Changes of CT
Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal
Study.Radiology 2020 08;296(2 ) :E55-E64 doi:10.1148/radiol.2020200843.
[29] Dai H, Zhang X, Xia J, etc. High-resolution Chest CT Features
and Clinical Characteristics of Patients Infected with COVID-19 in
Jiangsu, China. Int. J. Infect. Dis. 2020; 95: 106–112.
[30] Wang Y, Dong C, Hu Y, etc. Temporal Changes of CT Findings in
90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology
2020; 200843.
[31] Zhe Xu, Lei Shi, Yijin Wang, et al; Pathological findings of
COVID-19 associated with acute respiratory distress syndrome.The Lancet.
Respiratory medicine 2020 04;8(4):420-422
doi:10.1016/S2213-2600(20)30076-X.
[32] YuMiao Zhao, YaoMin Shang, Wen-Bin Song, etc; Follow-up study
of the pulmonary function and related physiological characteristics of
COVID-19 survivors three months after recovery.EClinicalMedicine 2020
Aug;25:100463 doi:10.1016/j.eclinm.2020.100463.
[33] Zhaohai Zheng, Fang Peng, Buyun Xu, et al; Risk factors of
critical & mortal COVID-19 cases: A systematic literature review and
meta-analysis.The Journal of infection 2020 08;81(2):e16-e25
doi:10.1016/j.jinf.2020.04.021.
[34] J Zhang, X Wang, X Jia,et al; Risk factors for disease
severity, unimprovement, and mortality in COVID-19 patients in Wuhan,
China.Clinical microbiology and infection : the official publication of
the European Society of Clinical Microbiology and Infectious Diseases
2020 Jun;26( 6 ) :767-772 doi:10.1016/j.cmi.2020.04.012.
[35] Haoming Zhu, Gaojing Qu, Hui Yu, Guoxin Huang, Lei Chen,
Meiling Zhang, Shanshan Wan, Bin Pei; Features of α-HBDH in COVID-19
patients: A cohort study.Journal of clinical laboratory analysis 2021
Jan;35(1 ) :e23690 doi:10.1002/jcla.23690.
[36] Huiping Yan, Yufen Tan, et al; A follow up study of total IgM,
IgG, nucleoprotein and spike protein antibodies against severe acute
respiratory syndrome ( SARS ) coronavirus in patients with SARS.Zhonghua
Jiehe Zazhi 2006 Nov;45( 11 ) :896-9.
[37] Cesheng Li, Ding Yu, Xiao Wu,et al; Twelve-month specific IgG
response to SARS-CoV-2 receptor-binding domain among COVID-19
convalescent plasma donors in Wuhan.Nature communications 2021 07 06;12(
1 ) :4144 doi:10.1038/s41467-021-24230-5.
[38] Baweleta Isho, Kento T Abe, Michelle Zuo, etc.Persistence of
serum and saliva antibody responses to SARS-CoV-2 spike antigens in
COVID-19 patients.Science immunology 2020 10 08;5( 52 )
doi:10.1126/sciimmunol.abe5511.
[37] Cesheng Li, Ding Yu, Xiao Wu, Hong Liang, et al; Twelve-month
specific IgG response to SARS-CoV-2 receptor-binding domain among
COVID-19 convalescent plasma donors in Wuhan.Nature communications 2021
07 06;12( 1 ) :4144 doi:10.1038/s41467-021-24230-5.